HK Stock Market Move | FOURSEMI (03625) rose nearly 9% to continue hitting new highs. Touch feedback chip adapts to multiple scenarios. The company is a participant in a fund under Fujian Investment Group.

FOURSEMI (03625) rose nearly 9%, reaching a high of 100.7 Hong Kong dollars during trading and setting a new high for the market. As of the time of publication, it had risen by 5.87% to 97.4 Hong Kong dollars with a trading volume of 26.7443 million Hong Kong dollars. In terms of news, the "AI Audio Chip First Stock" FOURSEMI Semiconductor recently officially listed on the Hong Kong Stock Exchange. According to public information, FOURSEMI's haptic feedback chip has achieved mature mass production and shipment, with its technical performance and market layout at the forefront in China, making it a core supplier in the field of domestic haptic feedback chips. Currently, in addition to being compatible with Siasun Robot & Automation, the chip has also completed technical adaptation in scenarios such as consumer electronics and smart homes, and has reached preliminary technical solutions with multiple Siasun Robot & Automation machine manufacturers. The technical compatibility and stability of the products have been recognized by the market, laying a solid foundation for the future commercialization in the Siasun Robot & Automation track. It is worth mentioning that FOURSEMI Semiconductor was invested in by a fund under the Fujian Investment Group and helped it list on the Hong Kong stock market. It is understood that in recent years, the Fujian Investment Group has continuously deepened its focus on strategic emerging industries such as semiconductors, new energy, and new materials through its platforms such as Fujian Industrial Investment Management and Fuchuang Investment, striving to create a complete "discovery-investment-incubation-listing" service system. As of now, the group has managed and invested in a total of 73 funds with a total scale of 85.4 billion yuan, investing in over 200 projects in Shenzhen New Industries Biomedical Engineering with a total amount exceeding 15 billion yuan. The proportion of investments in early-stage and growth-stage projects is close to 70%, successfully facilitating over 50 companies to list on domestic and foreign capital markets.